In Vitro Resistance Study of AG-021541, a Novel Nonnucleoside Inhibitor of the Hepatitis C Virus RNA-Dependent RNA Polymerase
about
Development of Intergenotypic Chimeric Replicons To Determine the Broad-Spectrum Antiviral Activities of Hepatitis C Virus Polymerase InhibitorsNaturally occurring dominant resistance mutations to hepatitis C virus protease and polymerase inhibitors in treatment-naïve patientsPreclinical Characterization of PF-00868554, a Potent Nonnucleoside Inhibitor of the Hepatitis C Virus RNA-Dependent RNA PolymeraseIdentification of HCV Resistant Variants against Direct Acting Antivirals in Plasma and Liver of Treatment Naïve PatientsClinical and in vitro resistance to GS-9669, a thumb site II nonnucleoside inhibitor of the hepatitis C virus NS5B polymerase.Targeting the non-structural proteins of hepatitis C virus: beyond hepatitis C virus protease and polymerase.Antiviral drugs against hepatitis C virus.Characterization of resistance to the nonnucleoside NS5B inhibitor filibuvir in hepatitis C virus-infected patients.Resistance mechanisms in HCV: from evolution to intervention.Lessons from HIV therapy applied to viral hepatitis therapy: summary of a workshop.New NS5B polymerase inhibitors for hepatitis C.Hepatitis C virus resistance to new specifically-targeted antiviral therapy: A public health perspective.Comparative study of the genetic barriers and pathways towards resistance of selective inhibitors of hepatitis C virus replication.Genotypic and phenotypic analyses of hepatitis C virus variants observed in clinical studies of VX-222, a nonnucleoside NS5B polymerase inhibitorNatural prevalence of hepatitis C virus (HCV) variants resistant to protease and polymerase inhibitors in patients infected with HCV genotype 1 in Tunisia.Pyridine Carboxamides: Potent Palm Site Inhibitors of HCV NS5B PolymeraseIn vitro anti-hepatitis C virus (HCV) resistance selection and characterization.Natural variation in drug susceptibility to HCV polymerase inhibitors in treatment-naïve HCV patient isolates.Hepatitis C virus variants with decreased sensitivity to direct-acting antivirals (DAAs) were rarely observed in DAA-naive patients prior to treatment.Specifically targeted antiviral therapy for hepatitis C virus.Antiviral activity of the hepatitis C virus polymerase inhibitor filibuvir in genotype 1-infected patients.Association of hepatitis C virus NS5B variants with resistance to new antiviral drugs among untreated patients.
P2860
Q27487022-0E718F98-638E-4402-A118-2C378E3E9D52Q27487949-05B13D4C-19D9-4F33-8B97-B5AC16749B4AQ27488428-B1177569-8479-4234-8309-BB3682B9B7D0Q33875539-7295E257-C2BE-4759-9F26-036D7726CC07Q34596328-252331CC-7CD5-4227-8C72-4CA5592D7D2DQ34620091-3914CB21-13D8-4193-A934-21A663CA9F9CQ35105567-184911DE-6F45-4498-A4F7-1A01971B3D25Q35806182-01596AF7-A8C7-4C07-BD13-2A2EEF0F4782Q37228736-39C95E9F-836E-4944-BE61-0285CB68A3E9Q37678183-B7127991-5081-4EE4-8ED9-AB049AA156A8Q37772518-CA29D4E2-FD28-48E7-9C62-691847CBBDEEQ38156875-EEA54672-B515-43F0-9499-21DC60B2648FQ38283239-A977A981-E569-47E3-A2E8-79D63E803EEEQ38427538-97C78911-3E88-46F5-88FC-F6999F8DE884Q38864459-E0E00999-B44D-46BD-A795-E985DA834F30Q39157657-6BD3FACD-AF63-41D5-BCE3-85D49CC3A0A8Q39470512-1C29B141-1409-4F1A-BDEA-F81386F0DC14Q39627463-D5BAE0E1-7CEC-4337-99E1-4DF0D85F8ABAQ42286521-F15EA2AB-34EA-437F-BDC3-7D8BE701EC37Q42909514-FF865A0C-8020-4E6E-8643-8C0CE7A16986Q43036045-ADBBB489-46F2-4FDE-82B5-4640852EA651Q43046674-DD5081AA-3DE1-4B84-8B60-BE26779B0D9B
P2860
In Vitro Resistance Study of AG-021541, a Novel Nonnucleoside Inhibitor of the Hepatitis C Virus RNA-Dependent RNA Polymerase
description
2008 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
article scientifique (publié 2008-02)
@fr
articolo scientifico (pubblicato il 2008-02)
@it
artigo científico (publicado na 2008-02)
@pt
artículu científicu espublizáu en 2008
@ast
im Februar 2008 veröffentlichter wissenschaftlicher Artikel
@de
scientific article (publication date: February 2008)
@en
vedecký článok (publikovaný 2008-02)
@sk
videnskabelig artikel (udgivet 2008-02)
@da
name
In Vitro Resistance Study of A ...... s RNA-Dependent RNA Polymerase
@ast
In Vitro Resistance Study of A ...... s RNA-Dependent RNA Polymerase
@en
In Vitro Resistance Study of A ...... s RNA-Dependent RNA Polymerase
@nl
type
label
In Vitro Resistance Study of A ...... s RNA-Dependent RNA Polymerase
@ast
In Vitro Resistance Study of A ...... s RNA-Dependent RNA Polymerase
@en
In Vitro Resistance Study of A ...... s RNA-Dependent RNA Polymerase
@nl
prefLabel
In Vitro Resistance Study of A ...... s RNA-Dependent RNA Polymerase
@ast
In Vitro Resistance Study of A ...... s RNA-Dependent RNA Polymerase
@en
In Vitro Resistance Study of A ...... s RNA-Dependent RNA Polymerase
@nl
P2093
P2860
P356
P1476
In Vitro Resistance Study of A ...... s RNA-Dependent RNA Polymerase
@en
P2093
Amy K Patick
Cristina Lewis
Fannie Chau
Hans Parge
Javier Gonzalez
Jingjin Gao
Joanne P Graham
Koleen J Herlihy
P2860
P304
P356
10.1128/AAC.00834-07
P407
P577
2008-02-01T00:00:00Z